CoreWeave vs Roivant Sciences Ltd. Common Shares — how do they compare? CoreWeave trades at $82.24 (market cap $44.99B), while Roivant Sciences Ltd. Common Shares trades at $35.08 (market cap $24.72B). The key difference: CoreWeave is the larger of the two by market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, CoreWeave nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold CoreWeave for 6 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| CRWV | ROIV | |
|---|---|---|
Market Cap | $44.99B | $24.72B |
Volume | 41,993,776 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $143.08 | $41.81 |
52-Week Low | $60.82 | $16.04 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $91.06B | $20.99B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
CoreWeave provides cloud computing infrastructure designed for AI workloads. Its platform gives organizations access to large-scale GPU computing and cloud services for training and running AI models.
Read more on CRWV →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →